LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
LabGenius has raised $64K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
LabGenius's investors include Inovia Capital, Lux Capital, Octopus Ventures, Felicis, Air Street Capital.
LabGenius is headquartered in London, United Kingdom.
LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
LabGenius is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LabGenius — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/labgenius. Accessed July 18, 2026.
VCBacked. (2026). LabGenius — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/labgenius
{{cite web |title=LabGenius — Funding & Investors |url=https://www.vcbacked.co/company/labgenius |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated